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Stroke in young has special signiﬁcance in developing countries. This is so because some etiologies like cardioembolic infections
are more common than in developed countries, and the aﬀection of economically productive group adds further to the overall
disease burden. The paper discusses the burden of stroke in young and its implications in a developing country like India along
with an approach to identifying diﬀerent causes that are known to occur in this age group.
1.Introduction
Stroke in young poses a major health problem. WHO deﬁnes
stroke as an event caused by the interruption of the blood
supply to the brain, usually because a blood vessel bursts
or is blocked by a clot. This cuts oﬀ the supply of oxygen
and nutrients, causing damage to the brain tissue [1]. The
most common symptom of a stroke is sudden weakness
or numbness of the face, arm, or leg, most often on one
side of the body, occurring in 90% of the strokes [2].
Other symptoms include confusion; diﬃculty speaking or
understanding speech; diﬃculty seeing with one or both
eyes; diﬃculty walking, dizziness, and loss of balance or
coordination;severeheadachewithnoknowncause;fainting
or unconsciousness. The eﬀects of a stroke depend on which
part of the brain is injured and how severely it is aﬀected. A
very severe stroke can cause sudden death.
Globally, stroke is the third commonest cause of mortal-
ity [3] and the fourth leading cause of disease burden [4].
It makes an important contribution to morbidity, mortality,
and disability in developed as well as developing countries.
In recent years, there has been increasing economic and
demographic development in developing countries result-
ing in a shift from diseases caused by poverty toward
chronic, noncommunicable, lifestyle-related diseases [5].
This happening in the younger age group adds to the
social burden, and as such these patients merit special
attention in diagnostic, therapeutic, and preventive care.
It leaves the patients with residual disabilities like physical
dependence, cognitive decline, depression, and seizures. The
review discusses the burden of stroke in young and its
implications in a developing country like India along with
approach to identifying diﬀerent causes that are known to
occur in this age group.
2.What Is So SpecialaboutStroke Occurring
inYoung?
A g ew i s es e g r e g a t i o no fc a s e si ns t r o k ei si m p o r t a n td u e
to several reasons. Age has been shown to have a strong
association with the incidence of stroke. While the peak age
of stroke occurrence is 55–65 years [6], events occurring
at a younger age assume importance in being occurring
in a productive age group and having a diﬀerent set
of causes which have to be looked into apart from the
conventional ones (Tables1,2,an d3).Theyarealsodiﬀerent
from childhood strokes which have been classiﬁed as those
occurring in less than ﬁfteen years of age.
Cerebral venous thrombosis and rheumatic heart disease
are the leading causes of stroke in the young in India [18].
Tubercular meningitis leading to arteritis or autoimmune
angiitis are also important stroke risk factors in young [19,
20]. Other Indian studies that have reported risk factors2 Stroke Research and Treatment
Table 1: Causes of stroke in young-Ischemic.
Cardioembolic Vasculitis Others
Common Less common Common Less common Common Less common
Rheumatic heart
disease Patent foramen ovale Infections Polyarteritis nodosa Atheroscler otic
vascular disease MELAS
Prosthetic valve Myxoma and other
tumors
Antiphospholipid
antibody syndrome
[7, 8]
Takayasu’s arteritis Arterial
dissection Prothrombotic states
Atrial ﬁbrillation Acute myocardial
infarction
Systemic lupus
erythematosus
Wegener’s
granulomatosis Sickle cell disorder
Bacterial
endocarditis Mitral valve prolapsed Protein C/S deﬁciency [9]
Atrial and ventricular
septal defects Fibromuscular dysplasia [10]
Polycythemia vera
Antithrombin III deﬁciency [11]
Paroxysmal
Nocturnal Hemoglobinuria
CADASIL and CARASIL [12]
Fabry’s disease
Familial hypercholesterolemia [13]
Thrombophilia [14]
Hyperhomocytienemia [15]
Migraine [16]
Hyperthyroidism [17]
Table 2: Causes of stroke in young-Hemorrhagic.
Common Less common
Arterio venous malformations Moya moya syndrome
Saccular aneurysms Arteritis (septic or mycotic)
Bleeding disorders Intracerebral tumors
Anticoagulants Substance abuse like
cocaine
Table 3: Causes of stroke in young-Venous.
Common Less common
Pregnancy Prothrombotic states
Postpartum Red blood cell disorders
Dehydration Bechet’s disease
Oral contraceptive Connective tissue disease
Other prothrombotic states
among the young include coagulopathy, elevated lipoprotein
(a), homocysteine, and elevated anticardiolipin antibodies
[21–25]. Some Indian studies have reported interesting
causes of stroke, like viper envenomation, and also suggested
mechanisms like squatting whilst on the toilet as an impor-
tant triggering factor for stroke in Indians, by raising the
blood pressure [26, 27]. A recent study from Pakistan [28]
in 50 young stroke patients also found infective meningitis
including tuberculosis meningitis and bacterial meningitis as
theleadingcauseofstroke(34%).Thesecondmostcommon
cause was cardioembolism (20%) comprising Valvular heart
diseases (14%), Cardiomyopathies (4%), and atrial myxoma
(2%). Hypertension was found in 14% cases. Pregnancy-
related causes (including Pregnancy-induced hypertension
and puerperal sepsis) were 12%. Systemic lupus erythe-
matous and nephritic syndrome was 4% each. Various
causes which constitute 4% or less were grouped together as
miscellaneous andthey include hyperhomocysteinaemiaand
hyperlipidaemias.
While the data from several studies worldwide in young
stroke population have realized that conventional risk factors
for all strokes still are most prevailing in young strokes
as well and while more than a decade-old Baltimore
Washington [29] study found cardiac embolism (31.1%),
hematologicandother(19.8%)smallvessel(lacunar)disease
(19.8%), nonatherosclerotic vasculopathy (11.3%), illicit
drug use (9.4%), oral contraceptive use (5.2%), large artery
atherosclerotic disease (3.8%), and migraine (1.4%) in their
428 young ischemic stroke patients, a later case series
from Rome [30] conﬁrmed smoking in 56% of patients,
hypertension in 23%, dyslipidemia in 15%, migraine in
26%, and diabetes mellitus in 2% in 394 young ischemic
stroke patients. Diabetes, hypertension, heart disease, cur-
rent smoking, and long-term heavy alcohol consumption
are major risk factors for stroke in young adults as in elder
population [31].
Data on primary intracerebral hemorrhage (ICH) in
young is scarce in India. Mehndiratta et al. [32]f o u n dStroke Research and Treatment 3
Table 4: Studies on stroke conducted in India.
Study Setting Results Comments
Abraham et al. [48], 1970, Vellore
Rural and urban,
community-based, all stroke
prevalence
Prevalence: 56.9/100,000
25% of the stroke patients
w e r eb e l o wt h ea g eo f4 0
years.
Bansal et al. [49], 1975, Rohtak Urban, community-based study,
all stroke prevalence
Population: 79,046
Prevalence: 44/100,000
GourieDevi et al. [50], 1987, Karnataka Rural, community based study,
all stroke prevalence
Population: 57,660
Prevalence: 52/100,000
Razdan et al. [37], 1989, Kashmir Rural, community based study,
all stroke prevalence
Population: 63,645
Prevalence: 143/100,000
10.9% of age group 15–39
years (prevalence rate
41/100,000)
Dalal et al. [51], 1989, Mumbai Urban, hospital based study,
1963–1968 and 1978–1982
Case fatality rate changed from 32
to 12% over this period Studied only young stroke
Nayak et al. [52], 1997, Kerela Hospital based, retrospective,
15–45 years of age 177 patients from 1988 to 1994. Studied clinical features
and risk factors in young
Mumbai stroke registry [53] Population based, urban, Jan to
Dec 2005, all age groups
Population: 1, 86,000
Crude incidence rate: 148/100, 000
77% ischemic,
hypertension in 25.3%
JIPMER stroke registry [53] Hospital based, 2005, all age
groups 105 in six months 36.2% patients <40 years
of age
Trivendrum stroke registry [53] Population-based, urban and
rural, 2005, all age groups
Population: 925,867
Crude incidence rate: 97.9/100,000
urban, 81.3/100,000 rural
Stroke in young 4.3%
Das et al. [36], 2007, Kolkata Population based, urban,
2003–2005, all age groups
Population: 52 377
Annual incidence rate
(AIR)123/100,000/year
AIR in <40 years
4.22/100,000/year
Lipska et al. [41], 2007, Kerala Case control study, 15–45 years,
ischemic stroke 214 cases, 195 controls,
Metabolic syndrome and
smoking-associated
ischemic stroke in young
Dalal et al. [54], 2008, Mumbai Population based study, all stroke
types, Jan 2005–Dec 2006
Population: 156,861
Annual incidence 145/100,000
in >25 years of age
Nagaraja et al. [55], 2009, Bangalore Hospital based, all stroke types 1174 patients 18% less than 40 years
of age
S. Kaul et al. [56], 2009, Hyderabad Hospital based, 2001–2005, all
stroke types
Annual incidence of stroke
145/100,000
10–15% of stroke in
young
ICH in their 18 (14.2%) of 127 young stroke patients.
Most common etiology was ruptured aneurysm (44.4%)
followed by ruptured Arteriovenous Malformations (AVM)
and hypertension (22.2% each) and eclampsia in 11.1%.
Causes of ICH in young in other parts of the world have
yielded variable results. The Hemorrhagic Stroke Project
(HSP) [33] had 217 out of 1714 patients with primary
ICH. The independent risk factors found were hypertension,
diabetes, menopause, current cigarette smoking, alcoholic
drinks > or =2/day, caﬀeinated drinks > or =5/day, and
caﬀeine in drugs.
3. Why Its Identiﬁcation Is Important in
DevelopingCountriesLikeIndia?
By 2050, it is anticipated that 80% of stroke events will
occur in people living in developing regions of the world
[34, 35]. Interestingly, the Kolkata study sample consisted
of mainly younger people (>80% were aged <60 years)
who are active in the workforce. When stroke occurs in
the main income earner in the household, there may be
enormous consequences for the welfare of the family [36].
Indian studies have shown that about 10% to 15% of
strokes occur in people below the age of 40 years [37].
It is believed that the average age of patients with stroke
in developing countries is 15 years younger than that in
developed countries [38, 39]. In India, nearly one-ﬁfth of
patients with ﬁrst ever strokes admitted to hospitals are
aged <40 years [40]. However, in the Trivandrum Stroke
Registry [41], only 3.8% of incident strokes occurred in
people aged <40 years, 9.5% aged <50 years, and 18.1%
aged <55 years; these data are very similar to that in
another community-based study from northeastern India
[36] and those from developed countries [42]. The reported
occurrence of stroke in the young, therefore, appears to be
largely an artifact related to hospital-based case ascertain-
ment [43].4 Stroke Research and Treatment
4. What Information Do We Have So Far about
Stroke inYoung inIndia?
Literature is available suggesting that risk of coronary artery
disease (CAD) is higher in Indians especially in the young
population [44, 45]. While we know that the risk factors for
stroke and coronary artery disease are same, recent studies
show that the risk of stroke may be comparable to other
populations [46, 47]. A number of well-designed prevalence
studies of stroke were carried out in hospital and community
invariouspartsofthecountryinthepastandrecently,which
have not only looked at risk factors but also focused upon
the young stroke population [41]. Table 4 shows the studies
conducted in various parts of India.
While these studies do reﬂect the enthusiasm of neurol-
ogists and stroke specialists in India to acquire knowledge
about stroke in young and stroke at large, the wider
community-based study is still wanting. The conventional
risk factors still play an important role in causation of stroke
in young [41], and genetic causation studies have evaluated
MTHFR polymorphisms [57, 58], alpha1 antichymotrypsin
[59], −344C/T aldosterone synthase (CYP11B2) [60], Phos-
phodiesterase 4D (PDE4D) [61], Prothrombin G20210A
[62], eNOS [63], and Angiotensin-converting enzyme [64]
genemutationinIndianstrokepatients.Thesemightassume
a greater importance in patients with family history of stroke
and young patients.
5. What Information Is Still Needed
from Studies?
More robust evidence is still required to dispel the myth
that young Indians are more susceptible to stroke [65].
The areas which require more information and insights are
intracerebral hemorrhage, cerebral venous sinus thrombosis
in young apart from ischemic stroke which forms the
majority and also the focus of stroke studies. Not only this,
the less conventional risk factors like migraine [16]a n d
patent foramen ovale [66], emerging factors like arterial
dissection [67], and established but less studied causes like
peripartum [68, 69] and infection [70, 71] need greater
evidence from India as well.
6. Limitations of the Review
As mentioned, deﬁnite answers are still required to answer
whether young Indians have increased susceptibility to
stroke. Most of the studies have a heterogeneous population
are hospital-based data with admission and selection bias.
Future studies should aim for a multicentric well-deﬁned
prospective evaluation on representative population samples
to acquire robust answers.
7. Conclusion
While it might turn out through more evidence that stroke
in young Indians might not be very diﬀerent from that in
other countries, the implications in a developing country are
many. Preventive measures could aid immensely in bringing
down costs and emotional burden on the family. But this
would need prior and correct identiﬁcation of burden and
risk factors prevailing in the community. Of added interest
would be risk factors, both acquired and genetic, which are
unique to this geographic area.
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